Leukemia

Latest News

A SEER-Medicare database analysis of patients with AML illustrates a trade-off between survival outcomes and time spent in hospitals.
Anthracyclines Improve Survival at the Expense of Home Time in AML

September 23rd 2024

A SEER-Medicare database analysis of patients with AML illustrates a trade-off between survival outcomes and time spent in hospitals.

Genomic subtype was associated with relapse, occurring in nearly 50% of PAX5-altered pediatric acute lymphoblastic leukemia cases.
Comprehensive Childhood ALL Genotyping May Optimize Risk Stratification

September 13th 2024

Earlier use of liso-cel may improve responses in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Liso-cel Shows Responses Across High-Risk Relapsed/Refractory CLL Subgroups

September 6th 2024

Treatment with CB-012 for patients with relapsed/refractory acute myeloid leukemia is under evaluation as part of the phase 1 AMpLify trial.
CB-012 Earns FDA Fast Track Status in R/R Acute Myeloid Leukemia

September 4th 2024

Phase 1/2 data support the fast track designation for BGB-16673 as a therapy for patients with relapsed/refractory chronic lymphocytic leukemia.
BTK Degrader BGB-16673 Earns FDA Fast Track Status in Pretreated CLL/SLL

August 26th 2024